Drug
Icp 488
Icp 488: highest development phase Phase 3, developed by InnoCare Pharma. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- InnoCare Pharma
Trials
| Drug | Phase | Indication |
|---|---|---|
| ICP-488 Tablets NCT06842199 | Phase 3 | Plaque Psoriasis Patients |
Latest
No recent events.
Follow Icp 488 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.